Skip to main content

DNA Damage Response Pathways meet Endocrine Systems

Cover image for Research Topic "DNA Damage Response Pathways meet Endocrine Systems"
43kviews
Editorial27 January 2023
Editorial: DNA damage response pathways meet endocrine systems

In an article entitled "Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma" Gu et al identified two distinct methylation subgroups among papillary thyroid carcinoma patients, termed the 'CpG island methylator phenotype' (CIMP) subgroup (high levels of DNA methylation) and nCIMP subgroup (low levels of DNA methylation). Authors investigated the impact of the different methylation patterns on patient's prognosis, immune profiles, epigenetic alterations and response to immune therapy or chemotherapy. They suggest that CIMP might serve as a tool for risk stratification and help to make medication guidelines for patients of different subtypes.In a paper entitled "Integrative analysis reveals novel associations between DNA methylation and the serum metabolome of adolescents with type 2 diabetes: A cross-sectional study" Agarwal et al conducted a cross-sectional integrated analysis of DNA methylation in peripheral blood mononuclear cells from adolescents with type 2 diabetes with serum metabolomic data. The objective of the study was to explore changes in the epigenetic landscape of white blood cells that might be associated with an altered serum metabolome. Authors identified differentially methylated regions in associations with a number of important metabolites in patients. Among others, metabolites include the free fatty acid receptor-1 (FFAR1), upstream transcription factor-2 (USF2), etc. Authors suggest that data may help generate new hypotheses regarding mechanisms that shape the metabolic profile.Mutations in the B-Raf proto-oncogene (BRAF) have been linked to a variety of solid tumors such as papillary thyroid carcinoma. In a paper entitled "A comparison of DP-TOF Mass Spectroscopy (MS) and Next Generation Sequencing (NGS) methods for detecting molecular mutations in thyroid nodules fine needle aspiration biopsies" authors compared DP-TOF, a DNA MS platform, and NGS methods for detecting multiple gene mutations (including BRAF V600E ) in aspiration fluid from 93 patients. Findings show that the MS method can be used as an inexpensive, accurate, and dependable initial screening method to detect gene mutations and as an adjunct to clinical diagnosis.Ewing sarcoma (EWS) is a poorly differentiated tumor with characteristic reciprocal chromosomal translocation, involving the EWS gene and one of the ETS family gene members, with high propensity for metastasis. EWS is the second most common primary tumor of bone and soft tissue in children and young people. Disruption of DNA methylation patterns represents a common feature of many forms of cancer and was proven to contribute to EWS pathogenesis. In an article entitled "Novel targeting of DNA methyltransferase activity inhibits Ewing sarcoma cell proliferation and enhances tumor cell sensitivity to DNA damaging drugs by activating the DNA damage response", Cristalli et al evaluate the efficacy of MC3343, a quinoline-based DNA methyltransferase (DNMT) inhibitor with high activity against cancer cells, including EWS. Authors demonstrate that MC3343 inhibits DNMT1 expression in EWS cells, but does not affect the methylation status of EWS cells. In addition, MC3343 slowed proliferation, induced DNA damage and cell death, and acted synergistically with other DNA damaging drugs, thereby indicating its potential use as a novel adjuvant therapeutic agent against EWS.Polycystic ovary syndrome (PCOS) is a prevalent endocrine disease in women associated with poor pregnancy outcomes. It is unknown whether sperm quality affects pregnancy outcomes of patients with PCOS. The effect of sperm DNA fragmentation on oocyte fertilization, embryonic development, and pregnancy outcomes for patients with PCOS who underwent in vitro fertilization (IVF) treatment is reported in a paper entitled "The effect of sperm DNA fragmentation on in vitro fertilization outcomes for women with polycystic ovary syndrome". Authors demonstrate that oocytes fertilized using sperm with a high DNA fragmentation index (DFI) led to a lower high-quality blastocyst formation rate but had no influence on fertilization, high-quality embryo, clinical pregnancy and miscarriage rates.The impact of female body mass index (BMI) on the DNA repair ability in oocytes after fertilization is unknown. Li et al evaluated the early embryo quality and reproductive outcomes of oocytes from overweight women when fertilized with sperm with varying degrees of DNA fragmentation. The paper, entitled "Decreased DNA repair ability: A mechanism for low early embryonic development potential of oocytes from overweight patients after fertilization in IVF cycles", is based on 1,612 patients undergoing fresh autologous IVF. Patients were divided into two groups according to maternal BMI (normal weight versus overweight) and each group was subdivided into two groups by sperm DNA fragmentation index [low (LF) versus high (HF) fragmentation]. For the normal weight group, there was no differences in embryo quality and reproductive outcomes between the LF and HF groups. However, in the overweight group, significantly lower fertilization rates, blastocyst development rates and high-quality blastocyst rates were found in the HF group, despite the similar pregnancy rates. Hence, decreased DNA repair activity in oocytes may be a possible mechanism for the low early development potential of embryos from overweight patients in IVF cycles.The diagnosis of follicular thyroid carcinoma (FTC) remains a challenge, as routine screening methods such as ultrasound could not diagnose FTC preoperatively. Yao et al performed an integrative analysis of DNA methylation and RNA array data aimed at identifying thyroid cancer-specific DNA methylation markers. The article, entitled "Integrative analysis of DNA methylation and gene expression identified follicular thyroid cancer-specific diagnostic biomarkers", was based on 14 FTC versus 16 benign thyroid lesions. Authors identified four DNA methylation sites that can be used as a potential screening tool for detection of FTC patients. Overall, the study demonstrates the potential use of methylation markers in FTC diagnosis.The feedback and feedforward regulatory mechanisms linking the endocrine systems to the DNA damage response pathway play central roles in various human disorders. The collection of papers presented in this RT further advances the understanding of intricacies of this system and how cells, tissues and organs modulate their responses and preserve homeostasis in the face of ever-changing conditions. Given their importance, endocrine system/DNA damage response biology is an intensely studied field, nevertheless many fundamental questions remain unanswered. For example, how coding and non-coding RNAs responses are coordinated by the endocrine system to avoid DNA-damage stress, what underlies the tissue-specific DNA damage responses, and how do cells modify their responses during cell division. Seeking answers to these and other questions is a fundamental research field for the near future.

1,642 views

Integrative analysis reveals novel associations between DNA methylation and the serum metabolome of adolescents with type 2 diabetes: A cross-sectional study
ORIGINAL RESEARCH
10 October 2022
Integrative analysis reveals novel associations between DNA methylation and the serum metabolome of adolescents with type 2 diabetes: A cross-sectional study
Prasoon Agarwal, 11 more and Vernon W. Dolinsky
Objective: Rates of type 2 diabetes (T2D) among adolescents are on the rise. Epigenetic changes could be associated with the metabolic alterations in adolescents with T2D. Methods: We performed a cross sectional integrated analysis of DNA methylation data from peripheral blood mononuclear cells with serum metabolomic data from First Nation adolescents with T2D and controls participating in the Improving Renal Complications in Adolescents with type 2 diabetes through REsearch (iCARE) cohort study, to explore the molecular changes in adolescents with T2D. Results: Our analysis showed that 43 serum metabolites and 36 differentially methylated regions (DMR) were associated with T2D. Several DMRs were located near the transcriptional start site of genes with established roles in metabolic disease and associated with altered serum metabolites (e.g. glucose, leucine, and gamma-glutamylisoleucine). These included the free fatty acid receptor-1 (FFAR1), upstream transcription factor-2 (USF2), and tumor necrosis factor-related protein-9 (C1QTNF9), among others. Conclusions: We identified DMRs and metabolites that merit further investigation to determine their significance in controlling gene expression and metabolism which could define T2D risk in adolescents.

5,035 views

16 citations

ORIGINAL RESEARCH
4 August 2022
A comparison of DP-TOF Mass Spectroscopy (MS) and Next Generation Sequencing (NGS) methods for detecting molecular mutations in thyroid nodules fine needle aspiration biopsies
Xiao-qin Qian, 10 more and Fei-ju Xu

3,907 views

7 citations

ORIGINAL RESEARCH
24 October 2022
Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma
Pengfei Gu, 8 more and Ming Gao

3,470 views

8 citations

Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response
ORIGINAL RESEARCH
31 May 2022
Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response
Camilla Cristalli, 12 more and Katia Scotlandi
DNA methylation is an important component of the epigenetic machinery that regulates the malignancy of Ewing sarcoma (EWS), the second most common primary bone tumor in children and adolescents. Coordination of DNA methylation and DNA replication is critical for maintaining epigenetic programming and the DNMT1 enzyme has been demonstrated to have an important role in both maintaining the epigenome and controlling cell cycle. Here, we showed that the novel nonnucleoside DNMT inhibitor (DNMTi) MC3343 induces a specific depletion of DNMTi and affects EWS tumor proliferation through a mechanism that is independent on DNA methylation. Depletion of DNMT1 causes perturbation of the cell cycle, with an accumulation of cells in the G1 phase, and DNA damage, as revealed by the induction of γH2AX foci. These effects elicited activation of p53-dependent signaling and apoptosis in p53wt cells, while in p53 mutated cells, persistent micronuclei and increased DNA instability was observed. Treatment with MC3343 potentiates the efficacy of DNA damaging agents such as doxorubicin and PARP-inhibitors (PARPi). This effect correlates with increased DNA damage and synergistic tumor cytotoxicity, supporting the use of the DNMTi MC3343 as an adjuvant agent in treating EWS.

4,738 views

16 citations

Integrative Analysis of DNA Methylation and Gene Expression Identified Follicular Thyroid Cancer-Specific Diagnostic Biomarkers
ORIGINAL RESEARCH
14 March 2022
Integrative Analysis of DNA Methylation and Gene Expression Identified Follicular Thyroid Cancer-Specific Diagnostic Biomarkers
Yunjin Yao, 10 more and Xiaoming Lou

4,871 views

16 citations

ORIGINAL RESEARCH
23 November 2021
Decreased DNA Repair Ability: A Mechanism for Low Early Embryonic Development Potential of Oocytes From Overweight Patients After Fertilization in IVF Cycles
Hui Li, 6 more and Qingling Yang

2,986 views

7 citations